Clinical trial NCT04251208 - References

Substance Use Disorders — MOms in REcovery (MORE) Study: Defining Optimal Care

Citation(s)

•   Armstrong MA, Gonzales Osejo V, Lieberman L, Carpenter DM, Pantoja PM, Escobar GJ
  Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol. 2003 Jan;23(1):3-9. doi: 10.1038/sj.jp.7210847.
•   Ashley OS, Marsden ME, Brady TM
  Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29(1):19-53. doi: 10.1081/ada-120018838.
•   Austin PC
  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011 May;46(3):399-424. doi: 10.1080/00273171.2011.568786. Epub 2011 Jun 8.
•   Back SE, Lawson KM, Singleton LM, Brady KT
  Characteristics and correlates of men and women with prescription opioid dependence. Addict Behav. 2011 Aug;36(8):829-34. doi: 10.1016/j.addbeh.2011.03.013. Epub 2011 Mar 25.
•   Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W
  Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011 Sep;37(5):313-23. doi: 10.3109/00952990.2011.596982.
•   Benningfield MM, Arria AM, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Fischer G, Jones HE, Martin PR
  Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict. 2010 Sep-Oct;19(5):416-21. doi: 10.1111/j.1521-0391.2010.00064.x.
•   Benningfield MM, Dietrich MS, Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Fischer G, Martin PR
  Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction. 2012 Nov;107 Suppl 1(0 1):74-82. doi: 10.1111/j.1360-0443.2012.04041.x.
•   Boyd SC, Marcellus L
  (2007) With child: substance use during pregnancy, a woman-centered approach. Halifax [N.S.]: Fernwood Pub.
•   Brener L, Resnick I, Ellard J, Treloar C, Bryant J
  Exploring the role of consumer participation in drug treatment. Drug Alcohol Depend. 2009 Nov 1;105(1-2):172-5. doi: 10.1016/j.drugalcdep.2009.06.016. Epub 2009 Jul 21.
•   Chander G, McCaul ME
  Co-occurring psychiatric disorders in women with addictions. Obstet Gynecol Clin North Am. 2003 Sep;30(3):469-81. doi: 10.1016/s0889-8545(03)00079-2.
•   Corse SJ, McHugh MK, Gordon SM
  Enhancing provider effectiveness in treating pregnant women with addictions. J Subst Abuse Treat. 1995 Jan-Feb;12(1):3-12.
•   Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC
  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50.
•   Damschroder LJ, Hagedorn HJ
  A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011 Jun;25(2):194-205. doi: 10.1037/a0022284.
•   Dowdell JA, Fenwick J, Bartu A, Sharp J
  Midwives' descriptions of the postnatal experiences of women who use illicit substances: a descriptive study. Midwifery. 2009 Jun;25(3):295-306. doi: 10.1016/j.midw.2007.03.008. Epub 2007 Jul 5.
•   Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF
  Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003 Mar;111(3):564-72. doi: 10.1542/peds.111.3.564.
•   Fiellin DA, Moore BA, Sullivan LE, Becker WC, Pantalon MV, Chawarski MC, Barry DT, O'Connor PG, Schottenfeld RS
  Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict. 2008 Mar-Apr;17(2):116-20. doi: 10.1080/10550490701860971.
•   Fitzsimons HE, Tuten M, Vaidya V, Jones HE
  Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat. 2007 Jan;32(1):19-25. doi: 10.1016/j.jsat.2006.06.015. Epub 2006 Oct 13.
•   Flavin J, Paltrow LM
  Punishing pregnant drug-using women: defying law, medicine, and common sense. J Addict Dis. 2010 Apr;29(2):231-44. doi: 10.1080/10550881003684830.
•   Flavin J
  (2002) A Glass Half Full? Harm reduction amongpregnant women who use cocaine. Journal of Drug Issues, 32(3):973-998. https://journals.sagepub.com/doi/10.1177/002204260203200315
•   Friedrichs A, Spies M, Harter M, Buchholz A
  Patient Preferences and Shared Decision Making in the Treatment of Substance Use Disorders: A Systematic Review of the Literature. PLoS One. 2016 Jan 5;11(1):e0145817. doi: 10.1371/journal.pone.0145817. eCollection 2016.
•   Goler NC, Armstrong MA, Taillac CJ, Osejo VM
  Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol. 2008 Sep;28(9):597-603. doi: 10.1038/jp.2008.70. Epub 2008 Jun 26. Erratum In: J Perinatol. 2009 Feb;29(2):181.
•   Hall JL, van Teijlingen ER
  A qualitative study of an integrated maternity, drugs and social care service for drug-using women. BMC Pregnancy Childbirth. 2006 Jun 13;6:19. doi: 10.1186/1471-2393-6-19.
•   Hedeker DR, Gibbons RD
  Wiley Series in Probability and Statistics: Longitudinal Data Analysis. 2006. ISBN-13: 978-0471420279
•   Heffner JL, Blom TJ, Anthenelli RM
  Gender differences in trauma history and symptoms as predictors of relapse to alcohol and drug use. Am J Addict. 2011 Jul-Aug;20(4):307-11. doi: 10.1111/j.1521-0391.2011.00141.x. Epub 2011 May 31.
•   Hesselink G, Johnson J, Batalden P, Carlson M, Geense W, Groenewoud S, Jones S, Roy B, Sansone C, Wolf JRLM, Bart B, Wollersheim H
  'Reframing Healthcare Services through the Lens of Co-Production' (RheLaunCh): a study protocol for a mixed methods evaluation of mechanisms by which healthcare and social services impact the health and well-being of patients with COPD and CHF in the USA and The Netherlands. BMJ Open. 2017 Sep 7;7(9):e017292. doi: 10.1136/bmjopen-2017-017292.
•   Hsieh HF, Shannon SE
  Three approaches to qualitative content analysis. Qual Health Res. 2005 Nov;15(9):1277-88. doi: 10.1177/1049732305276687.
•   Jansson LM, Svikis D, Lee J, Paluzzi P, Rutigliano P, Hackerman F
  Pregnancy and addiction. A comprehensive care model. J Subst Abuse Treat. 1996 Jul-Aug;13(4):321-9. doi: 10.1016/s0740-5472(96)00070-0.
•   Jansson LM, Velez ML
  Infants of drug-dependent mothers. Pediatr Rev. 2011 Jan;32(1):5-12; quiz 12-3. doi: 10.1542/pir.32-1-5. No abstract available.
•   Jones CM, Campopiano M, Baldwin G, McCance-Katz E
  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.
•   Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, Fischer G
  Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction. 2012 Nov;107 Suppl 1(0 1):5-27. doi: 10.1111/j.1360-0443.2012.04035.x.
•   Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G
  Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010 Dec 9;363(24):2320-31. doi: 10.1056/NEJMoa1005359.
•   Jones HE, Svikis D, Rosado J, Tuten M, Kulstad JL
  What if they do not want treatment?: lessons learned from intervention studies of non-treatment-seeking, drug-using pregnant women. Am J Addict. 2004 Jul-Sep;13(4):342-57. doi: 10.1080/10550490490483008.
•   Jones HE
  Treating opioid use disorders during pregnancy: historical, current, and future directions. Subst Abus. 2013;34(2):89-91. doi: 10.1080/08897077.2012.752779.
•   Jumah NA
  Rural, Pregnant, and Opioid Dependent: A Systematic Review. Subst Abuse. 2016 Jun 20;10(Suppl 1):35-41. doi: 10.4137/SART.S34547. eCollection 2016.
•   Killip S, Mahfoud Z, Pearce K
  What is an intracluster correlation coefficient? Crucial concepts for primary care researchers. Ann Fam Med. 2004 May-Jun;2(3):204-8. doi: 10.1370/afm.141.
•   Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD
  Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013. MMWR Morb Mortal Wkly Rep. 2016 Aug 12;65(31):799-802. doi: 10.15585/mmwr.mm6531a2.
•   Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, Chou R
  Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review. Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6.
•   Lagakos SW
  The challenge of subgroup analyses--reporting without distorting. N Engl J Med. 2006 Apr 20;354(16):1667-9. doi: 10.1056/NEJMp068070. No abstract available. Erratum In: N Engl J Med. 2006 Aug 3;355(5):533.
•   Lee J, Little TD
  A practical guide to propensity score analysis for applied clinical research. Behav Res Ther. 2017 Nov;98:76-90. doi: 10.1016/j.brat.2017.01.005. Epub 2017 Jan 19.
•   Lefebvre L, Midmer D, Boyd JA, Ordean A, Graves L, Kahan M, Pantea L
  Participant perception of an integrated program for substance abuse in pregnancy. J Obstet Gynecol Neonatal Nurs. 2010 Jan-Feb;39(1):46-52. doi: 10.1111/j.1552-6909.2009.01083.x.
•   McHugo GJ, Drake RE, Whitley R, Bond GR, Campbell K, Rapp CA, Goldman HH, Lutz WJ, Finnerty MT
  Fidelity outcomes in the National Implementing Evidence-Based Practices Project. Psychiatr Serv. 2007 Oct;58(10):1279-84. doi: 10.1176/ps.2007.58.10.1279.
•   Meyer M, Phillips J
  Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas. Prev Med. 2015 Nov;80:18-22. doi: 10.1016/j.ypmed.2015.07.015. Epub 2015 Jul 26.
•   Milligan K, Niccols A, Sword W, Thabane L, Henderson J, Smith A, Liu J
  Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis. Subst Abuse Treat Prev Policy. 2010 Sep 1;5:21. doi: 10.1186/1747-597X-5-21.
•   Molenberghs G, Kenward MG
  Missing Data in Clinical Studies. Chichester: Wiley; 2007. ISBN: 978-0-470-84981-1
•   Morgenstern J, Blanchard KA, McCrady BS, McVeigh KH, Morgan TJ, Pandina RJ
  Effectiveness of intensive case management for substance-dependent women receiving temporary assistance for needy families. Am J Public Health. 2006 Nov;96(11):2016-23. doi: 10.2105/AJPH.2005.076380. Epub 2006 Oct 3.
•   Najavits LM, Weiss RD, Shaw SR
  The link between substance abuse and posttraumatic stress disorder in women. A research review. Am J Addict. 1997 Fall;6(4):273-83.
•   Niccols A, Milligan K, Smith A, Sword W, Thabane L, Henderson J
  Integrated programs for mothers with substance abuse issues and their children: a systematic review of studies reporting on child outcomes. Child Abuse Negl. 2012 Apr;36(4):308-22. doi: 10.1016/j.chiabu.2011.10.007. Epub 2012 Apr 5.
•   Niccols A, Milligan K, Sword W, Thabane L, Henderson J, Smith A
  Integrated programs for mothers with substance abuse issues: A systematic review of studies reporting on parenting outcomes. Harm Reduct J. 2012 Mar 19;9:14. doi: 10.1186/1477-7517-9-14.
•   Oetzel JG, Villegas M, Zenone H, White Hat ER, Wallerstein N, Duran B
  Enhancing stewardship of community-engaged research through governance. Am J Public Health. 2015 Jun;105(6):1161-7. doi: 10.2105/AJPH.2014.302457. Epub 2015 Apr 16.
•   Oetzel JG, Zhou C, Duran B, Pearson C, Magarati M, Lucero J, Wallerstein N, Villegas M
  Establishing the psychometric properties of constructs in a community-based participatory research conceptual model. Am J Health Promot. 2015 May-Jun;29(5):e188-202. doi: 10.4278/ajhp.130731-QUAN-398. Epub 2014 Apr 10.
•   Olsen Y, Sharfstein JM
  Confronting the stigma of opioid use disorder--and its treatment. JAMA. 2014 Apr 9;311(14):1393-4. doi: 10.1001/jama.2014.2147. No abstract available.
•   Ordean A, Kahan M, Graves L, Abrahams R, Boyajian T
  Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study. Can Fam Physician. 2013 Oct;59(10):e462-9.
•   Ordean A, Kahan M, Graves L, Abrahams R, Kim T
  Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study. J Obstet Gynaecol Can. 2015 Mar;37(3):252-257. doi: 10.1016/S1701-2163(15)30311-X.
•   Patrick SW, Davis MM, Lehmann CU, Cooper WO
  Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015 Aug;35(8):650-5. doi: 10.1038/jp.2015.36. Epub 2015 Apr 30. Erratum In: J Perinatol. 2015 Aug;35(8):667. Lehman, C U [corrected to Lehmann, C U].
•   Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, Ely EW, Grijalva CG, Cooper WO
  Prescription opioid epidemic and infant outcomes. Pediatrics. 2015 May;135(5):842-50. doi: 10.1542/peds.2014-3299. Epub 2015 Apr 13.
•   Patrick SW, Schiff DM; COMMITTEE ON SUBSTANCE USE AND PREVENTION
  A Public Health Response to Opioid Use in Pregnancy. Pediatrics. 2017 Mar;139(3):e20164070. doi: 10.1542/peds.2016-4070. Epub 2017 Feb 20.
•   Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM
  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012 May 9;307(18):1934-40. doi: 10.1001/jama.2012.3951. Epub 2012 Apr 30.
•   Portela MC, Pronovost PJ, Woodcock T, Carter P, Dixon-Woods M
  How to study improvement interventions: a brief overview of possible study types. BMJ Qual Saf. 2015 May;24(5):325-36. doi: 10.1136/bmjqs-2014-003620. Epub 2015 Mar 25.
•   Reddy UM, Davis JM, Ren Z, Greene MF; Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes Workshop Invited Speakers
  Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol. 2017 Jul;130(1):10-28. doi: 10.1097/AOG.0000000000002054.
•   Roberts SC, Nuru-Jeter A
  Women's perspectives on screening for alcohol and drug use in prenatal care. Womens Health Issues. 2010 May-Jun;20(3):193-200. doi: 10.1016/j.whi.2010.02.003.
•   Roberts SC, Pies C
  Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care. Matern Child Health J. 2011 Apr;15(3):333-41. doi: 10.1007/s10995-010-0594-7.
•   Robins JM, Hernan MA, Brumback B
  Marginal structural models and causal inference in epidemiology. Epidemiology. 2000 Sep;11(5):550-60. doi: 10.1097/00001648-200009000-00011.
•   Saloner B, Karthikeyan S
  Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013. JAMA. 2015 Oct 13;314(14):1515-7. doi: 10.1001/jama.2015.10345. No abstract available.
•   Sandoval JA, Lucero J, Oetzel J, Avila M, Belone L, Mau M, Pearson C, Tafoya G, Duran B, Iglesias Rios L, Wallerstein N
  Process and outcome constructs for evaluating community-based participatory research projects: a matrix of existing measures. Health Educ Res. 2012 Aug;27(4):680-90. doi: 10.1093/her/cyr087. Epub 2011 Sep 21.
•   Schroedel JR, Fiber P
  Punitive versus public health oriented responses to drug use by pregnant women. Yale J Health Policy Law Ethics. 2001 Spring;1:217-35. No abstract available.
•   Seng JS, D'Andrea W, Ford JD
  Complex Mental Health Sequelae of Psychological Trauma Among Women in Prenatal Care. Psychol Trauma. 2014 Jan;6(1):41-49. doi: 10.1037/a0031467.
•   Shaw MR, Lederhos C, Haberman M, Howell D, Fleming S, Roll J
  Nurses' Perceptions of Caring for Childbearing Women who Misuse Opioids. MCN Am J Matern Child Nurs. 2016 Jan-Feb;41(1):37-42. doi: 10.1097/NMC.0000000000000208.
•   Simpatico TA
  Vermont responds to its opioid crisis. Prev Med. 2015 Nov;80:10-1. doi: 10.1016/j.ypmed.2015.04.002. Epub 2015 Apr 11.
•   Simpson TL, Miller WR
  Concomitance between childhood sexual and physical abuse and substance use problems. A review. Clin Psychol Rev. 2002 Feb;22(1):27-77. doi: 10.1016/s0272-7358(00)00088-x.
•   Stuart EA, Marcus SM, Horvitz-Lennon MV, Gibbons RD, Normand SL
  Using Non-experimental Data to Estimate Treatment Effects. Psychiatr Ann. 2009 Jul 1;39(7):41451. doi: 10.3928/00485713-20090625-07.
•   Terplan M, Kennedy-Hendricks A, Chisolm MS
  Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness. Subst Abuse. 2015 Sep 20;9(Suppl 2):1-4. doi: 10.4137/SART.S23328. eCollection 2015.
•   Terplan M, Ramanadhan S, Locke A, Longinaker N, Lui S
  Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database Syst Rev. 2015 Apr 2;(4):CD006037. doi: 10.1002/14651858.CD006037.pub3.
•   Thomas CP, Fullerton CA, Kim M, Montejano L, Lyman DR, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME
  Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv. 2014 Feb 1;65(2):158-70. doi: 10.1176/appi.ps.201300256.
•   Thompson MP, Kingree JB
  The frequency and impact of violent trauma among pregnant substance abusers. Addict Behav. 1998 Mar-Apr;23(2):257-62. doi: 10.1016/s0306-4603(97)00032-4.
•   Tuten M, Heil SH, O'Grady KE, Fitzsimons H, Chisolm MS, Jones HE
  The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse. 2009;35(5):358-63. doi: 10.1080/00952990903108231. Erratum In: Am J Drug Alcohol Abuse. 2010 Sep;36(5):304.
•   Tuten M, Jones HE
  A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend. 2003 Jun 5;70(3):327-30. doi: 10.1016/s0376-8716(03)00030-9.
•   Varadhan R, Segal JB, Boyd CM, Wu AW, Weiss CO
  A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research. J Clin Epidemiol. 2013 Aug;66(8):818-25. doi: 10.1016/j.jclinepi.2013.02.009. Epub 2013 May 4.
•   Wallerstein NB, Duran B
  Using community-based participatory research to address health disparities. Health Promot Pract. 2006 Jul;7(3):312-23. doi: 10.1177/1524839906289376. Epub 2006 Jun 7.
•   Westfall PH, Tobias RD, Wolfinger RD
  Multiple comparisons and multiple tests using SAS. Cary, N.C.: SAS Pub.; 2011
•   Wilder C, Lewis D, Winhusen T
  Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug Alcohol Depend. 2015 Apr 1;149:225-31. doi: 10.1016/j.drugalcdep.2015.02.012. Epub 2015 Feb 19.
•   Wright TE, Schuetter R, Fombonne E, Stephenson J, Haning WF 3rd
  Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J. 2012 Jan 19;9:5. doi: 10.1186/1477-7517-9-5.

MOms in REcovery (MORE): Defining Optimal Care for Pregnant Women and Infants

Details for clinical trial NCT04251208